•
TE
TELA
TELA Bio, Inc. Common Stock
polygonSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
--
Price Chart
Market Cap
43.42M
Volume
4.89K
52W High
$2.96
52W Low
$0.86
Open
$0.97
Prev Close
$0.98
Day Range
0.96 - 0.98
About TELA Bio, Inc. Common Stock
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
Latest News
Hernia Repair Devices Market is Set to Attain Valuation of US$ 6.57 Billion by 2033 | Astute Analytica
GlobeNewswire Inc.•Jun 25
TELA Bio Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Benzinga•Oct 24
TELA Bio Appoints Jeffrey Blizard to its Board of Directors
GlobeNewswire Inc.•Jun 4
TELA Bio Appoints Greg Firestone as Chief Commercial Officer
GlobeNewswire Inc.•May 20
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.•May 10
Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Top Estimates
Zacks Investment Research•May 6
The Joint Corp. (JYNT) Beats Q1 Earnings and Revenue Estimates
Zacks Investment Research•May 2
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
GlobeNewswire Inc.•Apr 15